Claims
- 1. A stable vaccine providing protection against disease comprising viral proteins transgenically expressed in plant cells.
- 2. The stable vaccine according to claim 1, wherein said disease is IBDV.
- 3. The stable vaccine according to claim 2, wherein said viral proteins are VP2, VP3 and VP4.
- 4. A stable vaccine providing protection against disease comprising viral protein coding sequences cloned into an E. Coli expression system.
- 5. The stable vaccine according to claim 4, wherein said disease is IBDV.
- 6. The stable vaccine according to claim 5, wherein said viral protein coding sequences encode VP2, VP3 and VP4.
- 7. A method of vaccination by:
transgenically expressing viral proteins capable of providing protection against disease into plant cells; and administering the plant cells to the animal in need of vaccination.
- 8. A method of vaccination by:
cloning viral protein encoding sequences capable of providing protection against disease into an E. Coli expression system; and administering the E. Coli to the animal in need of vaccination.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is a conversion of United States Provisional Patent Application Ser. No. 60/114,634, filed Jan. 4, 1999, incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60114634 |
Jan 1999 |
US |